The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Ab Initio Biotherapeutics; Forty Seven; Gilead Sciences; Pheast Therapeutics
Leadership - Ab Initio Biotherapeutics; Pheast Therapeutics
Stock and Other Ownership Interests - Ab Initio Biotherapeutics; Forty Seven; Gilead Sciences; Moderna Therapeutics
Consulting or Advisory Role - Ligand
Patents, Royalties, Other Intellectual Property - Patent US10316094B2, owned by Stanford University and licensed to Forty Seven, Inc.; Patent US9562087B2, owned by Stanford University and licensed to Ab Initio Biotherapeutics, Inc. (now owned by Ligand Pharmaceuticals); Patent US9845345B2, owned by Ab Initio Biotherapeutics, Inc. (now Ligand Pharmaceuticals).
Travel, Accommodations, Expenses - Forty Seven
Impact of magrolimab treatment in combination with azacitidine on red blood cells in patients with higher-risk myelodysplastic syndrome (HR-MDS).
 
James Yuhtyng Chen
Stock and Other Ownership Interests - Forty Seven
Consulting or Advisory Role - Forty Seven; Gilead Sciences
 
Lisa Johnson
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences; Takeda; Trillium Therapeutics
Patents, Royalties, Other Intellectual Property - Trillium Therapeutics
 
Kelly Marie McKenna
Stock and Other Ownership Interests - Forty Seven
Patents, Royalties, Other Intellectual Property - Forty Seven; Stanford
 
Timothy S. Choi
Employment - Gilead/Forty Seven
Stock and Other Ownership Interests - Forty Seven
 
Jiaqi Duan
Employment - Gilead Sciences
Stock and Other Ownership Interests - Forty Seven
 
Dongdong Feng
Employment - Bitterroot Bio; Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - TenSixteen Bio
 
Jonathan M. Tsai
Patents, Royalties, Other Intellectual Property - Stanford (FortySeven/Gilead)
 
Natalia Garcia-Martin
No Relationships to Disclose
 
Kavitha Sompalli
Employment - Beam Therapeutics; Bitterroot Bio
Stock and Other Ownership Interests - Beam Therapeutics; Forty Seven
Consulting or Advisory Role - Forty Seven
Patents, Royalties, Other Intellectual Property - Forty Seven
 
Roy Maute
No Relationships to Disclose
 
Paresh Vyas
Honoraria - Abbvie; Astellas Pharma; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals; Pfizer
Research Funding - Celgene
Patents, Royalties, Other Intellectual Property - Patent for flow cytometric detection of leukaemic stem cells
 
Ravindra Majeti
Leadership - BeyondSpring Pharmaceuticals; Forty Seven
Stock and Other Ownership Interests - BeyondSpring Pharmaceuticals; CiRC Biosciences; Erasca, Inc; Forty Seven; Pheast Therapeutics
Consulting or Advisory Role - BeyondSpring Pharmaceuticals; Coherus BioSciences; Forty Seven; Syros Pharmaceuticals
Research Funding - Bluestar Genomics; CiRC Biosciences; Gilead Sciences
Patents, Royalties, Other Intellectual Property - Gilead Sciences
 
Chris H.M. Takimoto
Employment - Gilead Sciences; IgM Biosciences
Leadership - IgM Biosciences
Stock and Other Ownership Interests - Gilead Sciences; IgM Biosciences
Consulting or Advisory Role - Overland Pharmaceuticals; Thetis Pharma
Patents, Royalties, Other Intellectual Property - Gilead Sciences
 
Jie Liu
Stock and Other Ownership Interests - Bitterroot Bio
Consulting or Advisory Role - Bitterroot Bio
Research Funding - Gilead Sciences (Inst)
Patents, Royalties, Other Intellectual Property - Gilead Sciences; Stanford
 
Giridharan Ramsingh
Employment - Gilead Sciences; Gilead Sciences
Stock and Other Ownership Interests - Genentech/Roche; Gilead Sciences
 
Mark Chao
Employment - Forty Seven; Gilead Sciences; TenSixteen Bio
Leadership - Forty Seven; TenSixteen Bio
Stock and Other Ownership Interests - Chimera Bioengineering; Forty Seven; Gilead Sciences; Hepatx; TenSixteen Bio; TigaTx
Honoraria - D2G Oncology
Consulting or Advisory Role - Chimera Bioengineering
Patents, Royalties, Other Intellectual Property - I am an inventor on patents licensed to Hepatx Inc.; I am an inventor on several patents from Stanford University that have been licensed to Forty Seven, Inc. I am also an inventor on patents generated from Forty Seven, Inc.
Travel, Accommodations, Expenses - Forty Seven; Gilead Sciences; TenSixteen Bio
 
Jens-Peter Volkmer
Employment - Bitterroot Bio; Forty Seven; Gilead Sciences
Leadership - Bitterroot Bio
Stock and Other Ownership Interests - Bitterroot Bio; Forty Seven
Patents, Royalties, Other Intellectual Property - Co-inventor on technologies that have been licensed to Forty Seven Inc and Gilead Sciences
 
Irving L. Weissman
Leadership - Forty Seven
Stock and Other Ownership Interests - Forty Seven
Consulting or Advisory Role - Forty Seven
Patents, Royalties, Other Intellectual Property - Forty Seven